Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARVN003 for Presbyopia
CTR20221337Phase 3Terminated
- Sponsor
- Jimu Biotechnology
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pilocarpine in presbyopia, sponsored by Jimu Biotechnology. Started May 2022; status: terminated.
02
Drugs
pilocarpine
03
Conditions
presbyopia
Beyond the preview
Go deeper on CTR20221337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20221337.